These guidelines indicate where there is evidence to support the use of long-term low-dose macrolides and where there is not. It discusses the potential benefits of such therapy for patients and also describes the potential risks to individuals and wider populations. It seeks to provide a pragmatic approach for clinicians considering long-term macrolide therapy for their patients.
This guidelines key points include – Oxygen is a treatment for hypoxaemia, not breathlessness, it has not been proven to have any consistent effect on the sensation of breathlessness in non-hypoxaemic patients; oxygen should be prescribed according to a target saturation range and those who administer oxygen therapy should monitor the patient and keep within the target saturation range; aim to achieve normal or near-normal oxygen saturation for all acutely ill patients apart from those at risk of hypercapnic respiratory failure or those receiving terminal palliative care.
The purpose of the Thoracic Society of Australia and New Zealand guidelines is to provide simple, practical evidence-based recommendations for the acute use of oxygen in adults in clinical practice.
Ataxia telangiectasia (A-T) is a rare, progressive, multisystem disease that has a large number of complex and diverse manifestations which vary with age. Patients with A-T die prematurely with the leading causes of death being respiratory diseases and cancer. Respiratory manifestations include
immune dysfunction leading to recurrent upper and lower respiratory infections; aspiration resulting from dysfunctional swallowing due to neurodegenerative deficits; inefficient cough; and interstitial lung disease/pulmonary fibrosis.
European Respiratory Society Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. This is a qualitative review which describes the epidemiological links between smoking and pulmonary disorders, the evidence for benefits of stopping smoking, how best to assess tobacco dependence and what interventions currently work best to help pulmonary patients quit as well as the management of any “hardcore” smoker who finds it difficult to quit with standard approaches.
British Thoracic Society (BTS) evidence-based guidance for the use of home oxygen for patients out of hospital. Predominantly covering evidence base from patients with COPD but the scope of the guideline covers patients with a variety of long-term respiratory illnesses ands in whom oxygen is currently used, such as in cardiac failure, cancer and end-stage
cardiorespiratory disease, terminal illness or cluster headache.
A consensus document for the selection of lung transplant candidates:2014 — An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation.
UK Guidelines from the National Institute for Health and Clinical Excellence on Smoking cessation in secondary care: acute, maternity and mental health services
Supporting smoking cessation: a guide for health professionals produced by the Royal Australian College of General Practitioners aims to be a practical, succinct and evidence based resource that can be used by a widerange of health professionals working in a variety of contexts.
British Thoracic Society recommendations on managing passengers with stable respiratory disease planning air travel.
Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient from the British Thoracic Society and the Association of Chartered Physiotherapists in Respiratory Care, a clinical interest subgroup of the Chartered Society of Physiotherapy
British Thoracic Society guidelines on respiratory aspects of fitness for diving